Search results for: 'Preferred Destination for Early Phase Clinical Trials'

The past 2 decades have been characterized by a tectonic shift in the global economic and business environment, with emerging markets increasingly finding their way into the growth and expansion plans of businesses across the globe. Gross domestic product (GDP) rates of emerging markets have fast outpaced that of developed economies, with accelera...

Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applications shaping the field. It assesses the competitive...

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-counter (OTC) CGM, growing adoption among non-insulin...

09 May 2025  |  Global  |  Market Research

Peripheral Vascular Devices Industry, Global, 2024–2029

Innovations in Drug-eluting Stents and Drug-coated Balloons are Driving Transformational Growth

Infographics

×

Frost & Sullivan observes that the shift to drug-eluting stents and drug-coated balloons will be the key trends driving the peripheral vascular devices industry during the forecast period. Investments in bioresorbable scaffolds will further drive the market growth. Drug-eluting bioresorbable scaffolds are an area of interest among industry stakehol...

09 Nov 2022  |  Global  |  Technology Research

Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis

Strategic partnering and new product development will enable better biologics for personalized and targeted treatment

Infographics

×

Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...

11 Jul 2019  |  North America  |  Market Research

Growth Opportunities in the Global Radiology-as-a-Service Market, Forecast to 2023

Innovative Business Models Focusing on Operational, Clinical, and Financial Excellence Witnessing Growing Adoption, Due to Increasing Influence of Value-based Care and Sustainable Healthcare Initiatives in the Imaging Ecosystem

Infographics

×

This Growth Opportunity service presents an analysis of the emerging ‘servitization’ business models in the medical imaging industry. With healthcare systems gradually transitioning to value-based care, imaging vendors across the value chain are positioning themselves as partners in this journey through risk-sharing and outcome-based services, with...

10 Jul 2015  |  Asia Pacific  |  Market Research

APAC Contract Research Organisation (CRO) Market

An Analysis of Trends Transforming the CRO Industry

Infographics

×

The research service presents an overview and analysis of the Asia-Pacific (APAC) contract research organisation (CRO) market and provides revenue forecasts by phase and therapeutic type. It discusses the major issues and challenges, unmet needs, and emerging trends in the market and covers the complete life cycle of the CRO industry, from pre-cli...

The global gamma radioactive sources market for NDT applications is segmented by sources into Iridium-192, Selenium-75, and Cobalt-60. For Iridium-192 and Selenium-75, detailed unit shipment forecast has been provided. Pricing analysis and market position ranking for the top participants in the market have also been given. As the Cobalt-60 market i...

11 Nov 2022  |  North America  |  Market Research

Global Contract Research Organization (CRO) Growth Opportunities

Strong Competitive Intensity is Mandating a Greater Industry Convergence Resulting in a Strong Market Growth

Infographics

×

Key Issues Addressed

The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were engaged in tremendous efforts to either develop new molecules or repurpose existing therapies as potential drugs for COVID-19 treatment. The trend is likely to continue with small-to-medium-segment and e...